Tanvex BioPharma, Inc. ("Tanvex"), a contract development and manufacturing organization (CDMO) for biologics and a biosimilars products company, is pleased to announce the successful completion ...

Key opinion leaders interviewed by GlobalData expressed optimism about biologics in COPD. Image: Jo Panuwat D via Shutterstock. The chronic obstructive pulmonary disease (COPD) market continues its ...

At the recent JP Morgan Healthcare Conference 2025, WuXi Biologics’ CEO Chris Chen said the company continues to sign foreign clients and investing in the US, despite political headwinds related to ...

Samsung Biologics has kicked off the start of 2025 with the largest single contract in the company's history, signing a record-breaking $1.41 billion deal, amounting to some 40 percent of the ...

RAMSEY, N.J. and BOCA RATON, Fla., Jan. 13, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial ...

Together, these assets will provide Telix with further in-house capabilities in antibody engineering and preclinical development, as well as a novel biologics platform to create the next generation of ...

A biosimilar biologic drug, or biosimilar, is a biologic drug that is highly similar to a biologic drug that was already authorized for sale (known as the reference biologic drug). Biosimilars may ...